Literatur
-
1
Dorrego MF, Canevaro L, Kuzis G, Sabe L, Starkstein SE.
A randomized, double blind, crossover study of methylphenidate and lithium in adults with attention deficit/hyperactivity disorder: Preliminary findings.
J Neuropsychiatry Clin Neurosci.
2002;
14
289-295
-
2
Krause J, Ryffel D Rawak.
Therapie der Aufmerksamkeitsdefizit/Hyperaktivitätsstörung im Erwachsenenalter.
Psycho.
2000;
26
209-223
-
3
Kuperman S, Perry PJ, Gaffney GR, Lund BC, Bever KA Stille, Arndt S, Holman TL, Moser DJ, Paulsen JS.
Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults.
Ann Clin Psychiatry.
2001;
13
129-134
-
4
Schubiner H, Saules KK, Arfken CL, Johanson E C, Schuster CR, Lockhart N, Edwards A, Donlin J, Pihlgren E.
Double blind placebo controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence.
Exp Clin Psychopharmacology.
2002;
10
286-294
-
5
The European Agency for the Evaluation of Medicinal Products (EMEA) .
Note for guidance on clinical investigation of medicinal products in children.
1997;
Korrespondenzadresse:
Prof. Dr. med. J. Fritze
Asternweg 65
50259 Pulheim
